0 337

Cited 2 times in

Sequencing of MET Inhibitors in Lung Cancer: Have We Met the Target?

DC Field Value Language
dc.contributor.author김창곤-
dc.contributor.author임선민-
dc.contributor.author조병철-
dc.date.accessioned2021-09-29T01:25:00Z-
dc.date.available2021-09-29T01:25:00Z-
dc.date.issued2021-05-
dc.identifier.issn1556-0864-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/184350-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherElsevier-
dc.relation.isPartOfJOURNAL OF THORACIC ONCOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHBenzamides-
dc.subject.MESHHumans-
dc.subject.MESHImidazoles-
dc.subject.MESHLung Neoplasms* / drug therapy-
dc.subject.MESHProtein Kinase Inhibitors / therapeutic use-
dc.subject.MESHTriazines-
dc.titleSequencing of MET Inhibitors in Lung Cancer: Have We Met the Target?-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorChang Gon Kim-
dc.contributor.googleauthorByoung Chul Cho-
dc.contributor.googleauthorSun Min Lim-
dc.identifier.doi10.1016/j.jtho.2021.02.017-
dc.contributor.localIdA05991-
dc.contributor.localIdA03369-
dc.contributor.localIdA03822-
dc.relation.journalcodeJ01909-
dc.identifier.eissn1556-1380-
dc.identifier.pmid33896567-
dc.identifier.urlhttps://www.sciencedirect.com/science/article/pii/S1556086421017354-
dc.contributor.alternativeNameKim, Chang Gon-
dc.contributor.affiliatedAuthor김창곤-
dc.contributor.affiliatedAuthor임선민-
dc.contributor.affiliatedAuthor조병철-
dc.citation.volume16-
dc.citation.number5-
dc.citation.startPage709-
dc.citation.endPage711-
dc.identifier.bibliographicCitationJOURNAL OF THORACIC ONCOLOGY, Vol.16(5) : 709-711, 2021-05-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.